Bicycle Therapeutics shares are trading lower after B. Riley Securities downgraded the stock from Buy to Neutral and lowered its price target from $33 to $28.
Portfolio Pulse from Benzinga Newsdesk
Bicycle Therapeutics shares are trading lower after B. Riley Securities downgraded the stock from Buy to Neutral and lowered its price target from $33 to $28.
August 07, 2024 | 7:41 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Bicycle Therapeutics shares are trading lower after B. Riley Securities downgraded the stock from Buy to Neutral and lowered its price target from $33 to $28.
The downgrade from Buy to Neutral and the reduction in the price target from $33 to $28 by B. Riley Securities is likely to negatively impact investor sentiment and lead to a short-term decline in Bicycle Therapeutics' stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100